Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Specialists Ask Congress To Drop Misvalued Code Provisions In Doc Payment Bill

This article was originally published in The Gray Sheet

Executive Summary

The Society for Cardiovascular Angiography and Interventions, North American Spine Society and other members of the Alliance of Specialty Medicine asked Congress Feb. 14 to drop the misvalued code provisions in proposed doc fix legislation, saying reimbursements should follow real costs of providing care.

You may also be interested in...



House Passes Physician Pay Patch With Imaging, Lab Provisions Supported by Industry

The House approved a one-year patch to avert Medicare physician payment cuts that includes industry-supported mandates for appropriate-use criteria for advanced imaging scans and more positive clinical laboratory payment policies for test makers. Senate votes on the one-year bill have been scheduled for March 31, but Finance Committee Chair Ron Wyden is still pushing members to pass a full SGR repeal and replace package.

News Briefs: PillCam Colon Clearance; CGM For Pediatrics; SGR Reform Bill

Given Imaging, soon to be part of Covidien, gained clearance for PillCam Colon capsule endoscopy device. FDA approves its first continuous glucose monitoring system for kids. Congress makes progress in the sustainable growth rate formula bill. More news.

House Physician Pay Bill Cheaper Than Senate Version, But Lacks Extenders

A pair of late-January estimates by the Congressional Budget Office of SGR reform bills prices the Senate Finance committee’s SGR bill at $150.4 billion and the House Ways and Means Committee’s version at $121 billion, but the House bill lacks important Medicare and Medicaid extenders due to expire soon.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033660

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel